Blood Sugar Drives Men's Sexual Health, iNKT Cell Therapy Achieves Remission, Researchers Target Galectin-1 for Liver Cancer, Early Peanut and Egg Introduction Lowers Allergies, and more... episode artwork

EPISODE · Jul 14, 2025 · 8 MIN

Blood Sugar Drives Men's Sexual Health, iNKT Cell Therapy Achieves Remission, Researchers Target Galectin-1 for Liver Cancer, Early Peanut and Egg Introduction Lowers Allergies, and more...

from Science News Daily · host brief.news

(0:10): Study Reveals Blood Sugar, Not Age or Testosterone, Key to Men's Sexual Health(1:40): Breakthrough: iNKT Cell Therapy Achieves First Complete Remission in Advanced Solid Tumors(3:27): Researchers Target Galectin-1 to Boost Liver Cancer Treatment Success and Reduce Recurrence(5:18): Early Peanut and Egg Introduction at Six Months Reduces Allergy Risk, Study Finds(6:49): World's Oldest Pigment Found: Ancient Pink Chlorophyll Offers Insight into Earth's Early LifeTo subscribe visit https://www.brief.news.For more updates in your inbox each morning visit www.brief.news. Image credit: Medical Xpress

Episode metadata supplied by the publisher feed · Published Jul 14, 2025

Embed this episode

Ready to play

Blood Sugar Drives Men's Sexual Health, iNKT Cell Therapy Achieves Remission, Researchers Target Galectin-1 for Liver Cancer, Early Peanut and Egg Introduction Lowers Allergies, and more...

0:00 8:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Science News Daily?

This episode is 8 minutes long.

When was this Science News Daily episode published?

This episode was published on July 14, 2025.

Can I download this Science News Daily episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!